Cargando…
Investigating the association between IL-6 antagonist therapy and blood coagulation in critically ill patients with COVID-19: a protocol for a prospective, observational, multicentre study
INTRODUCTION: Hypercoagulation is one the main features of COVID-19. It is induced by the hyperinflammatory response that shifts the balance of haemostasis towards pro-coagulation. Interleukin-6 (IL-6) antagonist therapy has been recommended in certain subgroups of critically ill patients with COVID...
Autores principales: | Kovács, Emőke Henrietta, Rottler, Máté, Dembrovszky, Fanni, Ocskay, Klementina, Szabó, László, Hegyi, Péter, Molnár, Zsolt, Tánczos, Krisztián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638747/ https://www.ncbi.nlm.nih.gov/pubmed/36332964 http://dx.doi.org/10.1136/bmjopen-2022-063856 |
Ejemplares similares
-
Effectiveness and safety of fibrinolytic therapy in critically ill patients with COVID-19 with ARDS: protocol for a prospective meta-analysis
por: Kovács, Emőke Henrietta, et al.
Publicado: (2022) -
Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Kovács, Emőke Henrietta, et al.
Publicado: (2022) -
Point-of-care ultrasound improves clinical outcomes in patients with acute onset dyspnea: a systematic review and meta-analysis
por: Szabó, Gergő Vilmos, et al.
Publicado: (2022) -
Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): protocol of a prospective, randomised, adaptive, multicentre clinical trial
por: Kanjo, Anna, et al.
Publicado: (2021) -
Individualized Hemodynamic Management in Sepsis
por: Virág, Marcell, et al.
Publicado: (2021)